Emerald Archiving closes doors
After nearly 15 years in the PACS archive outsourcing business, Emerald Archiving is calling it quits. The company officially closed its doors in December. Emerald provided backfile image conversion services to help PACS customers make the
After nearly 15 years in the PACS archive outsourcing business, Emerald Archiving is calling it quits. The company officially closed its doors in December. Emerald provided backfile image conversion services to help PACS customers make the transition from film to DICOM and to migrate from an existing archive to a new archive. Despite having worked with two dozen hospitals across the U.S., as well as some sites in Canada and Italy, the company was never able to turn a profit and ultimately ran out of money, according to former president and CEO Joe Friedman.
"The PACS market is going forward a lot more slowly than people expected, and we didn't have the financial backing to 'stay the course,'" he said. "But I still believe this is a valid concept and there is an opportunity for someone to have a viable company."
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
